A virtual community of physicians, scientists, and patients is helping Transparency Life Sciences develop three drugs for  multiple sclerosis, peripheral vascular disease, and inflammatory bowel disease.

The site (transparencyls.com), which is being managed by a handful of staff members in New York City and Boston, has only been live for a few weeks. It has attracted about 30 patients, who have been actively trading notes about their experiences and making suggestions for clinical trials